O.16 Current progress and preliminary results with the systemic administration trial of AVI-4658, a novel phosphorodiamidate morpholino oligomer (PMO) skipping dystrophin exon 51 in Duchenne muscular dystrophy (DMD)
- 31 October 2010
- journal article
- abstracts
- Published by Elsevier in Neuromuscular Disorders
- Vol. 20 (9) , 639-640
- https://doi.org/10.1016/j.nmd.2010.07.140
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: